The surging growth in digital health over the last decade may have slowed, but the potential of digital to transform healthcare remains. Digital health companies alongside pharma, MedTech, and other key stakeholders must come together and form strategic partnerships that play to their strengths.
The path to achieving digital health compliance in software as a medical device (SaMD) and digital health product development can feel like walking a tightrope. With compliance accounting for about 50% of development spend, the task is significant. What can we do about this?
Pharma-DTx partnerships can be a good strategy when both the pharma and the DTx companies speak the same language. While successful pilots have been demonstrated, there are challenges in scaling and sustaining innovations that generate value and return on investment (ROI) for pharma companies.